| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.006 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |